CuraGen and TopoTarget announce Southwest Oncology opens new lymphoma trial with PXD101.: An article from: BIOTECH Patent News [HTML] (Digital)

~ Gale Reference Team (Author)

Editorial Reviews

Product Description

This digital document is an article from BIOTECH Patent News, published by Thomson Gale on August 1, 2006. The length of the article is 1193 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: CuraGen and TopoTarget announce Southwest Oncology opens new lymphoma trial with PXD101.
Author: Gale Reference Team
Publication: BIOTECH Patent News (Newsletter)
Date: August 1, 2006
Publisher: Thomson Gale
Volume: 20 Issue: 8

Distributed by Thomson Gale

Product Details

• Format: HTML
• Printable: Yes
• Mac OS Compatible: Yes
• Windows Compatible: Yes
• Handheld Compatible: Yes
• File Size: 9 KB
• Digital: 4 pages
• Publisher: Thomson Gale (October 10, 2006)
• Average Customer Review: No customer reviews yet. Be the first.
• Required Free Software: Any web browser